Bioresorbable Stents Market is valued at USD 344.22 Million in 2020 and is expected to reach USD 780.18 Million by 2027 with a CAGR of 12.04% over the forecast period.
The Detailed Market intelligence report on the Bioresorbable Stent Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Bioresorbable Stent Market place for the forecast 2021– 2027.
The use of bioresorbable stents in interventional cardiology is a new approach in the treatment of coronary artery disease. This technology was introduced to overcome limitations of current metallic drug-eluting stents such as late in-stent restenosis and permanently caging the vessel. It is mainly aimed to provide temporal support to the vessel before being degraded and resorbed by the body, promoting vessel healing and restoration of vasomotion. Currently, there are several bioresorbable scaffolds that are under development with some already commercially available. The major advantages of bioresorbable stents include restoration of vessel anatomy (after resorption there is no segment straightening, no edges that could alter blood flow), restoration of vessel physiology as there is no metal cage full vasomotion is possible both in terms of cell signals and vessel relaxation/contraction, No thrombogenicity when the scaffold is resorbed and others.
Global Bioresorbable Stent market report is segmented on the basis of material, absorption rate, application, end-user, and region & country level. By material, the market is segmented into bioresorbable polymer-based stents and bioresorbable metallic stents. By absorption rate, the market is segmented into slow absorption stents and fast absorption stents. By application, the market is segmented into coronary artery diseases and peripheral artery diseases. By end-user, the market is segmented into hospitals and cardiac centers.
The regions covered in this Bioresorbable stent Market report are North America, Europe, Asia-Pacific, and the Rest of the World. On the basis of country level, the market of Bioresorbable stent is subdivided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
Some major key players for the global Bioresorbable stent market are,
An increasing number of patients of heart attack and people who are stroke susceptible are the major factors driving the demand for the bioabsorbable stent. For example; according to the Centers for Disease Control and Prevention; 735,000 Americans suffer a heart attack each year. Additionally, without a permanent metal structure left behind, natural and important functions of the artery vessel such as vasomotion and normalization of shear stress patterns resume is also supplementing the market demand for bioabsorbable stents. Furthermore, the busy lifestyle, unhealthy foods and less physical activity increase the chances of having cardiovascular disease and foster market growth. However, high cost, government regulations and other issues with stent are hindering the market. Moreover, technological advancement to develop more innovative bioabsorbable stents can create opportunities for the further growth of the market.
North America is expected to account for the largest share of the global bioresorbable stent market. This growth is mainly attributed to high prevalence of cardiovascular diseases, the busy lifestyle and unhealthy foods heart disease in this region. For example; as per U.S. Department of Health & Human Services; In the United States, someone has a heart attack every 40 seconds. Every year, about 805,000 Americans have a heart attack. Additionally, increasing the number of cases of stent implants yearly in this region is also fostering the market growth. North America is followed by Europe due to the increasing technological advancements and growing awareness about the benefits of bioresorbable stent usage. Asia pacific is expected to witness significant growth in this market owing to the growing awareness regarding advantages of PCI procedures, and increased R&D investments on innovative coronary stents in this region.
|2015 - 2020
|2021 - 2027
|Market Size in 2020:
|USD 344.22 Million
|Base year considered
|Forecast Period CAGR %:
|Market Size Expected in 2027:
|USD 780.18 Million
|Tables, Charts & Figures:
|Bioresorbable Stents Manufacturers
|Abbott, BIOTRONIK SE & Co. KG, REVA Medical, Inc, Elixir Medical Corporation, Arterial Remodeling Technologies, Kyoto Medical Planning Co. Ltd, Microport Scientific Corporation, Arterius Ltd, Terumo Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Meril Life Sciences Pvt. Ltd., Medtronic plc, Smith & Nephew Plc, Stryker Corporation, Q3 Medical Devices Limited., ORBUSNEICH MEDICAL, JW Medical Systems LTD, and others.
|By Material, By Absorption Rate, By End User
|North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa
Middle East and Africa
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us email@example.comJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®